• leader board size
Case Studies2020-11-19T22:10:23-08:00

Case Studies

Cresco Labs Reports Q1 2026 Financial Results

CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...

Cronos Group Reports Q1 2026 Financial Results

TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC ...

3WIN Corp Acquires Alchemist Filling Machines

TEMPE - 3WIN Corp., a distributor of CCELL vape hardware and a provider of services to the Cannabis industry, announced it has acquired Alchemist Filling Machines, an Arizona company known for its patent-protected equipment used ...

Cresco Labs Reports Q1 2026 Financial Results

CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...

Cronos Group Reports Q1 2026 Financial Results

TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC ...

DEA Moves to Reclassify Cannabis to Schedule III

LOS ANGELES- The U.S. Drug Enforcement Administration (DEA) is reportedly planning to reclassify cannabis from a Schedule I to a Schedule III substance under the Controlled Substances Act, a change confirmed by anonymous sources and ...

US DEA To Reclassify Cannabis In Historic Move

WASHINGTON, D.C.- In a landmark development, the Drug Enforcement Administration (DEA) has made a historic decision, concurring with the recommendations of the top federal health agency to reclassify cannabis from Schedule I to Schedule III ...

Lophos Holdings Inc. Expands Peyote Cultivation

Lophos Holdings Inc.  — Lophos Holdings Inc., through its subsidiary Lophos Pharmaceuticals Corp., announces the successful planting of 3,000 peyote seeds, significantly surpassing its initial cultivation target of 1,000 plants for the year 2024. This ...

RIV Capital Fiscal Update and Strategic Developments

NEW YORK- RIV Capital Inc. an investment and acquisition firm, today reported its financial outcomes for the fiscal quarter and the nine-month period ending December 31, 2023. This period marks a transition following the adjustment ...

California Moves Closer to Legalizing Cannabis Cafés

LOS ANGELES- California's legislative efforts to allow cannabis cafés took a significant step forward as Assembly Bill 1775, championed by Representative Matt Haney (D), passed through a second Assembly committee. The bill received favorable votes ...

Expanded Record Sealing Opportunities Approved in Maine

LOS ANGELES- Maine's Legislature has recently approved two significant bills that enhance the state's ability to seal criminal records. Among these, one particular bill stands out for its focus on cannabis-related offenses. This legislation now ...

DEA Challenges Right to Try Psilocybin Use in Court

LOS ANGELES- The U.S. Drug Enforcement Administration (DEA) has requested a federal appeals court to refuse Dr. Sunil Aggarwal's application to use psilocybin for terminally ill patients, citing the Controlled Substances Act (CSA) which does ...

Subscribe To Our Newsletter

Go to Top